Serum adiponectin levels are associated with worse cognitive function in postmenopausal women.
Pasquale De FranciscisMichelangela BarbieriStefania LeoAnna Maria DaliseCelestino SarduRaffaele MarfellaNicola ColacurciGiuseppe PaolissoMaria Rosaria RizzoPublished in: PloS one (2017)
A significant positive association may exist between serum adiponectin levels, and better cognitive function in postmenopausal status. The major determinant of attentional capacity was just serum adiponectin levels, and dosage of serum adiponectin levels may be early serum marker of cognitive decline. Therefore, serum adiponectin level has to be used, as early biomarker, to detect cognitive decline, and to support an early prevention.